Novo Nordisk A/S ADR buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€120.00
Target price
01.04.25
€148.38
Performance (%)
-3.33%
Price
02.05.24
€116.00
Summary
This prediction is currently active. With a performance of -3.33%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 01.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | -1.277% | -1.277% |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $160.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€121.00
20.03.24
20.03.24
€147.49
20.03.25
20.03.25
-3.63%
02.05.24
02.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€112.50
20.02.24
20.02.24
€129.46
20.02.25
20.02.25
3.66%
02.05.24
02.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€114.00
14.02.24
14.02.24
€130.44
14.02.25
14.02.25
2.29%
02.05.24
02.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€106.50
01.02.24
01.02.24
€128.80
01.02.25
01.02.25
9.50%
02.05.24
02.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€93.20
01.12.23
01.12.23
€110.39
01.12.24
01.12.24
25.12%
02.05.24
02.05.24